Diabetic Nephropathy
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-09-26FDA Approved: RAMIPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for RAMIPRIL from Hikma Pharmaceuticals USA Inc. under ANDA077900.
-
FDA approval · 2014-09-26FDA Approved: RAMIPRIL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for RAMIPRIL (ramipril) from Zydus Lifesciences Limited.
-
FDA approval · 2014-09-25FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (AiPing Pharmaceutical, Inc.)
FDA approved a supplemental application for Losartan Potassium from AiPing Pharmaceutical, Inc. under an ANDA, indicating an additional appr…
-
FDA approval · 2014-09-25FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves a supplemental application for a generic Losartan Potassium product from Alembic Pharmaceuticals Limited.
-
FDA approval · 2014-09-21FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for Losartan Potassium from Quallent Pharmaceuticals Health LLC to update the approved generic p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-09-21FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Losartan Potassium submitted by Aurobindo Pharma Limited.
-
FDA approval · 2014-09-19FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for Losartan Potassium (generic), granting a supplemental approval for the prod…
-
CLINICAL_TRIALS research · 2014-08-19Clinical Trial Update: Effect of Magnesium Supplementation on Patients With Diabetic Nephropathy [NA]
A clinical trial is studying magnesium supplementation in patients with diabetic nephropathy, with the status listed as unknown.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting. [NA]
A completed clinical trial evaluating an integrated chronic kidney disease care program for patients with early diabetic nephropathy in a pr…
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease [Phase 4]
Phase 4 trial evaluating aldosterone breakthrough during Diovan, Tekturna, and combination therapy in proteinuric kidney disease was termina…
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: The Effects of Sevelamer Carbonate on Diabetic Nephropathy [Phase 2]
A Phase 2 clinical trial evaluating sevelamer carbonate for diabetic nephropathy has been completed, with no results detailed in the snippet…
-
CLINICAL_TRIALS research · 2014-02-13Clinical Trial Update: Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy [Phase 4]
This update describes a Phase 4 clinical trial focused on developing technology to validate surrogate prognostic markers in patients with di…
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function [Phase 1]
A Phase 1 single-dose study evaluating Technosphere Inhalation Powder (inhaled insulin) in diabetic subjects with mild or moderate nephropat…
-
CLINICAL_TRIALS research · 2013-12-16Clinical Trial Update: Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy [NA]
A clinical trial update about beraprost sodium and arterial stiffness in patients with diabetic nephropathy. The study status is currently u…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Renoprotection in Early Diabetic Nephropathy in Pima Indians [Phase 3]
Phase 3 trial evaluating renoprotective strategies in early diabetic nephropathy among Pima Indians; trial completed with results posted in …
-
CLINICAL_TRIALS research · 2013-11-15Clinical Trial Update: Impact of c242T Polymorphism of p22phox in Diabetic type1 Nephropathy
Clinical trial investigating the role of the c242T polymorphism of p22phox in diabetic nephropathy among individuals with Type 1 diabetes; t…
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: 1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy [Phase 4]
A completed Phase 4 trial compared telmisartan 80 mg to valsartan 160 mg over one year in hypertensive patients with type 2 diabetes and ove…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy [Phase 4]
This is a Phase 4 clinical trial update for Telmisartan (Micardis) in incipient diabetic nephropathy, sponsored by Boehringer Ingelheim; the…
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients [Phase 4]
Phase 4 trial evaluating triple blockade of the renin-angiotensin-aldosterone system in proteinuric diabetic patients (Type 1 and Type 2) ha…
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy [Phase 2]
A Phase 2 multicenter, double-blind, placebo-controlled study evaluating atrasentan, including thoracic bioimpedance, in adults with type 2 …
-
CLINICAL_TRIALS research · 2013-10-16Clinical Trial Update: Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease [NA]
This trial update investigates increased activity of the renal ENaC transporter in diabetic nephropathy, with relevance to hypertension.
-
CLINICAL_TRIALS trial_result · 2013-09-23Clinical Trial Update: A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy [Phase 1]
A Phase 1 study evaluating the safety and tolerability of PF-03882845 in patients with diabetic nephropathy due to type 2 diabetes. The tria…
-
CLINICAL_TRIALS research · 2013-09-06Clinical Trial Update: The Genetics of Kidneys in Diabetes (GoKinD) Study
The GoKinD study investigated genetic factors influencing diabetic nephropathy in diabetes and has completed data collection.
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor [Phase 2]
A Phase 2 trial evaluated the efficacy and safety of once-daily atrasentan tablets (low and high doses) versus placebo in reducing residual …
-
FDA approval · 2013-08-16FDA Approved: LISINOPRIL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901))
FDA approved a supplemental application for generic lisinopril from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals), authorizing a cha…